# FDA 483 - Mayo Clinic PET Radiochemistry Facility - September 24, 2025

Source: https://www.keypedia.com/records/483/mayo-clinic-pet-radiochemistry-facility/d79fe46b-fb84-455f-ad32-1c2c96fea706

> FDA 483 for Mayo Clinic PET Radiochemistry Facility on September 24, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Mayo Clinic PET Radiochemistry Facility
- Inspection Date: 2025-09-24
- Product Type: drugs
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of Mayo Clinic PET Radiochemistry Facility in Rochester, MN, revealed significant deficiencies in production and process controls for sterile PET drug manufacturing. These issues include inadequate microbiological testing media controls, failures in sterile filter integrity testing, insufficient environmental monitoring, and poor cleaning and disinfection practices in critical aseptic areas. The findings indicate a high risk of microbial contamination, potentially compromising the quality and purity of sterile PET drug products.

## Related Officers

- [Regulatory Affairs Specialist](https://www.keypedia.com/people/andrew-le/573464c0-de29-4f64-ab33-62543b7fe719)

Company: https://www.keypedia.com/companies/mayo-clinic-pet-radiochemistry-facility/6b2304d3-2e0e-4a40-9b2d-5a95a9a873cf

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d